These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 35601967

  • 1. Neurocognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: Long-term mature outcomes of a prospective study.
    Gupta T, Kalra B, Goswami S, Deodhar J, Rane P, Epari S, Moiyadi A, Dasgupta A, Chatterjee A, Chinnaswamy G.
    Neurooncol Pract; 2022 May; 9(3):236-245. PubMed ID: 35601967
    [Abstract] [Full Text] [Related]

  • 2. Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy.
    Gupta T, Jalali R, Goswami S, Nair V, Moiyadi A, Epari S, Sarin R.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):1534-40. PubMed ID: 22342098
    [Abstract] [Full Text] [Related]

  • 3. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C, Grill J, Figarella-Branger D, Bernier V, Padovani L, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Baron MH, Clavere P, Chapet S, Maingon P, Alapetite C, Claude L, Laprie A, Dussart S.
    J Clin Oncol; 2009 Apr 10; 27(11):1879-83. PubMed ID: 19273707
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
    Câmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M, Quality of Survival Working Group of the Brain Tumour Group of SIOP-Europe.
    Int J Radiat Oncol Biol Phys; 2015 Aug 01; 92(5):978-985. PubMed ID: 26194675
    [Abstract] [Full Text] [Related]

  • 6. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC, Donahue B, DaRosso R, Nirenberg A.
    Int J Radiat Oncol Biol Phys; 1996 Dec 01; 36(5):1155-61. PubMed ID: 8985038
    [Abstract] [Full Text] [Related]

  • 7. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P, Mulhern RK, Regine WF, Rivera GK, Kun LE.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):561-6. PubMed ID: 7852120
    [Abstract] [Full Text] [Related]

  • 8. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma).
    Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, Rorke LB, D'Angio GJ.
    Int J Radiat Oncol Biol Phys; 1996 Mar 01; 34(4):899-904. PubMed ID: 8598368
    [Abstract] [Full Text] [Related]

  • 9. The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.
    Kao GD, Goldwein JW, Schultz DJ, Radcliffe J, Sutton L, Lange B.
    Cancer; 1994 Aug 01; 74(3):965-71. PubMed ID: 8039126
    [Abstract] [Full Text] [Related]

  • 10. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM.
    J Clin Oncol; 2001 Aug 01; 19(15):3470-6. PubMed ID: 11481352
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors.
    Goda JS, Dutta D, Krishna U, Goswami S, Kothavade V, Kannan S, Maitre M, Bano N, Gupta T, Jalali R.
    Neuro Oncol; 2020 Nov 26; 22(11):1677-1685. PubMed ID: 32227185
    [Abstract] [Full Text] [Related]

  • 12. Medulloblastoma in childhood: What effects on neurocognitive functions?
    Khalil J, Chaabi S, Oberlin O, Sialiti S, Hessissen L, Benjaafar N.
    Cancer Radiother; 2019 Sep 26; 23(5):370-377. PubMed ID: 31331843
    [Abstract] [Full Text] [Related]

  • 13. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE, Schreiber JE, Wu S, Lukose R, Xiong X, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2014 Nov 01; 90(3):554-61. PubMed ID: 25160611
    [Abstract] [Full Text] [Related]

  • 14. Prospective longitudinal assessment of sensorineural hearing loss with hyperfractionated radiation therapy alone in patients with average-risk medulloblastoma.
    Gupta T, Mohanty S, Kannan S, Jalali R.
    Neurooncol Pract; 2014 Sep 01; 1(3):86-93. PubMed ID: 31386031
    [Abstract] [Full Text] [Related]

  • 15. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ.
    Lancet Oncol; 2016 Mar 01; 17(3):287-298. PubMed ID: 26830377
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma.
    Eaton BR, Fong GW, Ingerski LM, Pulsifer MB, Goyal S, Zhang C, Weyman EA, Esiashvili N, Klosky JL, MacDonald TJ, Ebb DH, MacDonald SM, Tarbell NJ, Yock TI.
    Cancer; 2021 Oct 15; 127(20):3840-3846. PubMed ID: 34255345
    [Abstract] [Full Text] [Related]

  • 18. Omission of Upfront Craniospinal Irradiation in Patients with Low-Risk WNT-Pathway Medulloblastoma Is Associated with Unacceptably High Risk of Neuraxial Failure.
    Gupta T, Pervez S, Dasgupta A, Chatterjee A, Epari S, Chinnaswamy G, Jalali R.
    Clin Cancer Res; 2022 Oct 03; 28(19):4180-4185. PubMed ID: 35653134
    [Abstract] [Full Text] [Related]

  • 19. Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.
    Fay-McClymont TB, Ploetz DM, Mabbott D, Walsh K, Smith A, Chi SN, Wells E, Madden J, Margol A, Finlay J, Kieran MW, Strother D, Dhall G, Packer RJ, Foreman NK, Bouffet E, Lafay-Cousin L.
    J Neurooncol; 2017 May 03; 133(1):119-128. PubMed ID: 28405869
    [Abstract] [Full Text] [Related]

  • 20. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK, Palmer SL, Merchant TE, Wallace D, Kocak M, Brouwers P, Krull K, Chintagumpala M, Stargatt R, Ashley DM, Tyc VL, Kun L, Boyett J, Gajjar A.
    J Clin Oncol; 2005 Aug 20; 23(24):5511-9. PubMed ID: 16110011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.